|
시장보고서
상품코드
2008098
체외진단(IVD) 원료 시장 : 제품별, 기술별, 최종사용자별, 지역별IVD Raw Materials Market, By Product, By Technology, By End-User, By Geography |
||||||
체외진단(IVD) 원료 시장은 2026년에 342억 8,160만 달러로 추정되며, 2033년까지 507억 9,060만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.8%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 342억 8,160만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.80% | 예측 금액(2033년) | 507억 9,060만 달러 |
체외진단(IVD)은 질병이나 질환을 감지하고 전반적인 건강 상태를 모니터링하여 질병의 치료, 관리 및/또는 예방에 도움을 줄 수 있습니다. 체외진단약은 심혈관질환, 암, 당뇨병, 감염성 질환, 신장질환, 자가면역질환, HIV/에이즈 등 다양한 의학적 질환의 진단에 활용되고 있습니다. IVD는 인체에서 채취한 혈액 샘플이나 조직 샘플을 이용하여 검사하는 것을 말합니다. 요컨대, IVD의 원료는 사람의 건강 상태를 판단하는 데 사용됩니다. 체외진단(IVD) 시약 및 키트의 주요 원료에는 항체, 항원, 효소 등이 포함되며, 이는 시약 및 키트의 품질과 효능을 결정짓는 중요한 요소입니다.
시장 역학
COVID-19의 유행, 만성질환의 높은 유병률, 체외 진단 기술의 발전, 현장 진단의 사용 확대, 고령 인구 증가, 동반진단의 중요성 증가는 예측 기간 동안 세계 IVD 원료 시장의 성장을 촉진할 것으로 예상되는 주요 요인 중 일부입니다.
2021년 8월, 로슈는 미국 식품의약국(FDA)으로부터 항 PD-1 면역치료 대상인 dMMR 고형암 환자를 식별하기 위한 'VENTANA MMR RxDx Panel'에 대한 승인을 획득했습니다. 또한, 2020년 5월 ERBA Diagnostics Mannheim GmbH는 SARS-CoV-2에 대한 IgG 및 IgM 항체를 검출하기 위한 면역 측정법 기반 키트인 ErbaLisa COVID-19 ELISA 키트를 출시하였다고 발표하였습니다. 2020년 3월, Abbott는 COVID-19 진단용 PCR 검사 'RealTime SARS-CoV-2 assay'를 출시했고, 바이오메딕스(Biomedimics)는 15분 이내에 혈액 내 항체를 검출할 수 있는 현장진단형 COVID-19 검사를 출시했습니다.
본 보고서의 주요 특징
- 세계의 IVD 원료 시장을 상세히 분석하고, 2021년을 기준 연도로 하여 예측 기간(2022-2030년)의 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 세계 IVD 원료 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 매개 변수를 기반으로 정리하여 수록하고 있습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 종류 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 IVD 원료 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 IVD 원료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 IVD 원료 시장 : 제품별(2026-2033년)
제5장 세계의 IVD 원료 시장, 기술별(2026-2033년)
제6장 세계의 IVD 원료 시장 : 최종사용자별(2026-2033년)
제7장 세계의 IVD 원료 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSMIVD Raw Materials Market is estimated to be valued at USD 34,281.6 Mn in 2026 and is expected to reach USD 50,790.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 34,281.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 50,790.6 Mn |
In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits.
Market Dynamics
The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period.
In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes.
Key features of the study
- This report provides in-depth analysis of the global IVD raw materials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global IVD raw materials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, Thermo Fisher Scientific, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global IVD raw materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IVD raw materials market.
Market Segmentation
- Global IVD Raw Materials Market, By Product
- Antibodies & Antigens
- Enzymes
- Proteins
- Biological Buffers
- Others
- Global IVD Raw Materials Market, By Technology
- Clinical Chemistry
- Immunochemistry
- Molecular diagnostics
- Others
- Global IVD Raw Materials Market, By End-User
- Pharma, Biotech & MedTech Companies
- Diagnostic Laboratories
- Others
- Global IVD Raw Materials Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global IVD Raw Materials Market: Key Players
- Aalto Bio Reagents
- Fapon Biotech
- Fujirebio
- Merck KgaA
- Hoffmann-La Roche
- Thermo Fisher Scientific
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global IVD Raw Materials Market, By Product, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Antibodies & Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Biological Buffers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global IVD Raw Materials Market, Technology, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Clinical Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Immunochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Molecular diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global IVD Raw Materials Market, By End User, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Pharma, Biotech & MedTech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
7. Global IVD Raw Materials Market, By Geography, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- South Africa
- Central Africa
- North Africa
- Rest of World
8. Competitive Landscape
- Aalto Bio Reagents
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fapon Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujirebio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
